Hacker Newsnew | past | comments | ask | show | jobs | submitlogin
Kimberly-Clark is buying Tylenol maker Kenvue in cash and stock deal worth –$48B (apnews.com)
8 points by healsdata 49 days ago | hide | past | favorite | 3 comments


Would be interesting to see whether and how anyone at Kimberly-Clark, or any of its shareholders, cozied up to Trump and/or RFK Jr. before the whole MAHA "acetaminophen causes autism" bit happened; and when, exactly, Kimberly Clark started looking into acquiring Kenvue.


Not sure where the '-' came from, it's regular +$48b


Ah crap. I tried to put ~ since the original headline had the word "about" but I must have typo'd.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: